AT386599B - Verfahren zur herstellung von neuen 3-(amino oder substituierte amino)-4-(substituierte amino)-1,2, 5-thiadiazolen - Google Patents

Verfahren zur herstellung von neuen 3-(amino oder substituierte amino)-4-(substituierte amino)-1,2, 5-thiadiazolen

Info

Publication number
AT386599B
AT386599B AT0111083A AT111083A AT386599B AT 386599 B AT386599 B AT 386599B AT 0111083 A AT0111083 A AT 0111083A AT 111083 A AT111083 A AT 111083A AT 386599 B AT386599 B AT 386599B
Authority
AT
Austria
Prior art keywords
amino
substituted amino
thiadiazoles
producing new
substituted
Prior art date
Application number
AT0111083A
Other languages
German (de)
English (en)
Other versions
ATA111083A (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority to AT0139387A priority Critical patent/AT397655B/de
Publication of ATA111083A publication Critical patent/ATA111083A/de
Application granted granted Critical
Publication of AT386599B publication Critical patent/AT386599B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT0111083A 1982-03-29 1983-03-29 Verfahren zur herstellung von neuen 3-(amino oder substituierte amino)-4-(substituierte amino)-1,2, 5-thiadiazolen AT386599B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0139387A AT397655B (de) 1982-03-29 1987-06-01 Verfahren zur herstellung von neuen substituierten äthandiimidamiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (2)

Publication Number Publication Date
ATA111083A ATA111083A (de) 1988-02-15
AT386599B true AT386599B (de) 1988-09-12

Family

ID=23429274

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0111083A AT386599B (de) 1982-03-29 1983-03-29 Verfahren zur herstellung von neuen 3-(amino oder substituierte amino)-4-(substituierte amino)-1,2, 5-thiadiazolen

Country Status (30)

Country Link
JP (2) JPS58180477A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880002209B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT386599B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU557577B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE896291A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH660880A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS250240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (2) DD219768A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3311281A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (2) DK166677B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES8404683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2542741B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB2117769B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU196386B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE55596B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL68259A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1164633B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU84716A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY8700942A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8301063A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO163055C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ203726A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA07356A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT76459B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE461040B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (2) SU1419518A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU44849B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA832154B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZW (1) ZW7683A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033169A1 (de) * 1979-09-04 1981-03-19 Bristol-Myers Co., New York, N.Y. 3,4-disubstituierte 1,2,5-thiadiazol-1-oxide und -1,1-dioxide
EP0040696A2 (en) * 1980-04-30 1981-12-02 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033169A1 (de) * 1979-09-04 1981-03-19 Bristol-Myers Co., New York, N.Y. 3,4-disubstituierte 1,2,5-thiadiazol-1-oxide und -1,1-dioxide
EP0040696A2 (en) * 1980-04-30 1981-12-02 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors

Also Published As

Publication number Publication date
LU84716A1 (fr) 1983-12-05
GB2117769B (en) 1985-08-29
AU1290783A (en) 1983-10-06
ES527685A0 (es) 1985-06-16
SE8301725L (sv) 1983-11-25
ES527686A0 (es) 1985-06-16
NO163055B (no) 1989-12-18
GB2149406A (en) 1985-06-12
NO163055C (no) 1990-03-28
MY8700942A (en) 1987-12-31
GB2149406B (en) 1986-01-02
SE8704689D0 (sv) 1987-11-25
ES520982A0 (es) 1984-05-16
NO831100L (no) 1983-09-30
SU1355123A3 (ru) 1987-11-23
CS250240B2 (en) 1987-04-16
ES8505977A1 (es) 1985-06-16
IL68259A0 (en) 1983-06-15
AU557577B2 (en) 1986-12-24
KR840004095A (ko) 1984-10-06
GR78524B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-27
DD219768A5 (de) 1985-03-13
GB2117769A (en) 1983-10-19
IT8348005A0 (it) 1983-03-28
CH655111A5 (de) 1986-03-27
NL8301063A (nl) 1983-10-17
IE55596B1 (en) 1990-11-21
DK81192A (da) 1992-06-18
OA07356A (fr) 1984-08-31
NZ203726A (en) 1986-05-09
HU188742B (en) 1986-05-28
ES8404683A1 (es) 1984-05-16
DE3311281A1 (de) 1983-11-24
IT1164633B (it) 1987-04-15
HU196386B (en) 1988-11-28
ES8505978A1 (es) 1985-06-16
AU6327286A (en) 1987-01-08
FR2597867A1 (fr) 1987-10-30
SE461040B (sv) 1989-12-18
CH660880A5 (de) 1987-05-29
JPH06135925A (ja) 1994-05-17
DK81192D0 (da) 1992-06-18
FR2542741B1 (fr) 1989-12-08
GB8308518D0 (en) 1983-05-05
YU74483A (en) 1986-02-28
YU44849B (en) 1991-04-30
JPS58180477A (ja) 1983-10-21
IE830686L (en) 1983-09-29
SU1419518A3 (ru) 1988-08-23
PT76459A (en) 1983-04-01
DK141383D0 (da) 1983-03-28
PT76459B (en) 1986-03-11
BE896291A (fr) 1983-09-28
DD210909A5 (de) 1984-06-27
DK141383A (da) 1983-09-30
AU586037B2 (en) 1989-06-29
KR880002209B1 (ko) 1988-10-18
SE8301725D0 (sv) 1983-03-28
GB8432809D0 (en) 1985-02-06
ZW7683A1 (en) 1984-01-04
ZA832154B (en) 1983-12-28
ATA111083A (de) 1988-02-15
DK166677B1 (da) 1993-06-28
FR2597867B1 (fr) 1989-12-08
CS250229B2 (en) 1987-04-16
SE8704689L (sv) 1987-11-25
SE464302B (sv) 1991-04-08
JPH0568472B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-09-29
FR2542741A1 (fr) 1984-09-21

Similar Documents

Publication Publication Date Title
ATA271885A (de) Verfahren zur herstellung von neuen aromatischen heterocyclischen verbindungen
AT369008B (de) Verfahren zur herstellung von neuen festen solvaten aus syn-7-(2-(2-amino-4-thiazolyl)-2-
AT387771B (de) Verfahren zur herstellung von neuen oxazolidinen
ATA450783A (de) Verfahren zur herstellung von neuen trehaloselipiden
AT364368B (de) Verfahren zur herstellung des neuen 3-methylmercapto-4-amino-6-(1-methylcyclopropyl)-1,2,4triazin-5-ons
ATA206483A (de) Verfahren zur herstellung von neuen mitosanderivaten
ATA125383A (de) Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
AT388161B (de) Verfahren zur herstellung von neuen 2,5-piperazindionderivaten
AT386599B (de) Verfahren zur herstellung von neuen 3-(amino oder substituierte amino)-4-(substituierte amino)-1,2, 5-thiadiazolen
AT378958B (de) Verfahren zur herstellung von neuen derivaten des 1,4-chinolyl-2-(4-piperidyl)-aethanols oder des 1,4-chinolyl-3-(4-piperidyl)-propanols und deren salzen
AT376970B (de) Verfahren zur herstellung von 2,3-dihydro-2,2dimethyl-7-hydroxybenzofuran
AT365588B (de) Verfahren zur herstellung von neuen spiropyridochroman-4',5-hydantoinen
AT380233B (de) Verfahren zur herstellung von neuen 1,7,7
AT380881B (de) Verfahren zur herstellung des neuen 3-(4-phenyl-1-piperazinio-1-yl)-1,2-propandiol-(theophyllin-7-yl)-1-propansulfonats
AT374203B (de) Verfahren zur herstellung von neuen 2'-desoxy-3', 5'-di-o-alkylcarbonyl-5-fluoruridinderivaten
AT387385B (de) Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen
ATA269579A (de) Verfahren zur herstellung von neuen 2,5-dihydro -1,2-thiazino-(5,6-b)indol-3-carboxamid-1,1- dioxiden und von deren salzen
AT371452B (de) Verfahren zur herstellung von 5-amino-1,2,3 thiadiazolen
DE3575922D1 (de) Verfahren zur herstellung von 3,5-disubstituierten isoxazolen.
ATA87685A (de) Verfahren zur herstellung von s- 3morpholino-4- (3'-tert-butylamino-2'-hydroxypropoxy)-1,2,5thiadiazol
AT378776B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT373872B (de) Verfahren zur herstellung von 2,2-dialkyl-4-methyl-5,5-dialkyl-3-formyl-3-pyr olinen
ATA185885A (de) Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols
AT373890B (de) Verfahren zur herstellung von neuen 1,4;3,6-dianhydro-2,5-diazido-2,5-didesoxy-hexit-derivaten
AT382374B (de) Verfahren zur herstellung von neuen n-substituierten ergolin- und 9,10-didehydroergolin-8-carboxamid-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
ELJ Ceased due to non-payment of the annual fee